Initial Experience of Subcutaneous Implantable Cardioverter Defibrillator

Subcutaneous Implantable Cardioverter Defibrillator: Early Experience

INTRODUCTION The implantable cardioverter defibrillator had been increasing the survival of patients at high risk for sudden cardiac death. The subcutaneous implantable cardioverter defibrillator was developed to mitigate the complications inherent to lead placement into cardiovascular system. OBJECTIVE To report the initial experience of 18 consecutive cases of subcutaneous implantable cardi...

Subcutaneous implantable cardioverter-defibrillator.

or nearly 3 decades, the implantable cardioverter-defibrillator (ICD) has been available to patients who survived life-threatening rapid heart rhythms or are at risk of experiencing them. The ICD comprises a device generator coupled with a defibrillation lead. Traditional ICDs are implanted under the skin with the generator positioned beneath the collar bone. The defibrilla-tion lead is inserte...

Subcutaneous implantable cardioverter defibrillator.

Intermuscular pocket for subcutaneous implantable cardioverter defibrillator: Single-center experience

The subcutaneous implantable cardioverter defibrillator (S-ICD) is a novel device now accepted in clinical practice for treating ventricular arrhythmias. In 14 consecutive patients, S-ICD devices were placed in the virtual space between the anterior surface of the serratus anterior muscle and the posterior surface of the latissimus dorsi muscle. During a mean follow up of 9 months, no dislocati...

Implantation of the Subcutaneous Implantable Cardioverter-Defibrillator

The subcutaneous implantable cardioverter-defibrillator (S-ICD) was introduced to reduce acute transvenous leadrelated complications, such as pneumothorax, endocarditis, cardiac perforation, and lead dislodgements, as well as the complications related to chronic indwelling leads, such as lead failure, venous obstruction, and bacteremia. The standard implantation technique of the S-ICD involves ...